Title: Cantor Fitzgerald Reiterates Overweight Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)
Author: MarketBeat News
Source: newsapi
Published: 2024-12-15T07:35:08Z
URL: https://www.etfdailynews.com/2024/12/15/cantor-fitzgerald-reiterates-overweight-rating-for-biomarin-pharmaceutical-nasdaqbmrn/
----------------------------------------
Cantor Fitzgerald reissued their overweight rating on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a research note issued to investors on Thursday,Benzinga reports. The brokerage … [+5820 chars]